Hospital for Special Surgery Trademark Application for "RM RIGHTMOVE" Made Available to Public

According to the latest filings, a trademark application has been made for "RM RIGHTMOVE" by Lori E. Harrison PROSKAUER ROSE LLP, representing Hospital for Special Surgery. The application provides details on the goods and services the trademark will cover, including provision of online health and consultative services in the field of musculoskeletal care to corporate employers and their employees.

Key Takeaways:

  • The trademark application, made available on October 02, 2025, is for the name "RM RIGHTMOVE" and covers goods and services in the field of musculoskeletal care.
  • The applicant, Lori E. Harrison PROSKAUER ROSE LLP, represents Hospital for Special Surgery in the trademark application.
  • The application specifies that the trademark will cover online health and consultative services, including telehealth services, telehealth triage, and online medical and physical therapy services.
  • The registrar information for this application is: Lori E. Harrison PROSKAUER ROSE LLP, ELEVEN TIMES SQUARE, NEW YORK, NY 10036-8299, United States.
  • The trademark application falls under international trademark goods and services class code 044.
  • The tradmarked logo features the colors blue and green as a distinctive feature.
  • Hospital for Special Surgery's decision to trademark "RM RIGHTMOVE" may signal a significant shift in their telemedicine services, targeting corporate employers for their employees' musculoskeletal care needs.

Statistics:

  • The trademark application serial number is 97690461.
  • The goods and services class code for this trademark application is 044.
  • The trademark application was made available to the public on October 02, 2025.
  • The applicant, Lori E. Harrison PROSKAUER ROSE LLP, has expertise in trademark law and is representing Hospital for Special Surgery in this legal matter.

Sources:

  • NewsRx journal, Washington, D.C., October 21, 2025
  • NewsRx, Telemedicine Week, 2025
  • NewsRx LLC, copyright 2025